Articles in refereed journals

  • Dandash O, …, Russell N,..., Kanaan RA (2024). The effect of estradiol add-back: a longitudinal MRI study in prostate cancer patients. Endocrine Connections (online ahead of print): DOI: 10.1530/EC-23-0409.

  • Warren AM, Grossmann M, Christ-Crain M, Russell N (2023). Syndrome of inappropriate antidiuresis: from pathophysiolgy to management. Endocr Rev (online ahead of print): DOI: 10.1210/endrev/bnad010.

  • Russell N, Hoermann R, Cheung AS, Zajac JD, Grossmann M (2022). Effects of oestradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trial. Eur J Endocrinol 187 (5):617-627. DOI: 10.1530/EJE-22-0318.

  • Zanker J, Sim M, …, Russell N,..., Daly RM, Scott D (2022). Consensus guidelines for sarcopenia prevention, diagnosis and management in Australia and New Zealand. J Cachexia Sarcopenia Muscle (accepted). DOI: 10.1002/jcsm.13115.

  • Russell N, Ghasem-Zadeh A, Hoermann R, Cheung AS, Zajac JD, Shore-Lotenti C, Ebeling PR, Handelsman DJ, Grossmann M (2022). Effects of estradiol on bone in men undergoing androgen deprivation therapy: a randomized placebo-controlled trial. Eur J Endocrinol 187 (2): 241-256. DOI: 10.1530/EJE-22-0227.

  • Warren AM, Grossmann M, Hoermann R, Zajac JD, Russell N (2022). Tolvaptan versus fluid restriction in acutely hospitalised patients with moderate-profound hyponatraemia (TVFR-HypoNa): Design and implementation of an open-label randomised trial. Trials 23 (1): 335. DOI 10.1186/s13063-022-06237-5.

  • Russell N, Allebone J, Dandash O, Hoermann R, Cheung AS, Zajac JD, Handelsman DJ, Kanaan RA, Grossmann M (2022). Effect of estradiol on cognition in men undergoing androgen deprivation therapy: a randomized trial. Clin Endocrinol (Oxf) (Online ahead of print). DOI: 10.1111/cen.14689.

  • Russell N, Hoermann R, Cheung AS, Zajac JD, Handelsman DJ, Grossmann M (2021). Effects of estradiol on fat mass in men undergoing androgen deprivation therapy: a randomized trial. Eur J Endocrinol 186 (1): 9-23. DOI: 10.1530/EJE-21-0663.

  • Ramchand SK, Russell N, Grossmann M (2021). Optimising bone health during endocrine therapy for hormone sensitive cancer. Endocrinology Today 10 (4). 14-18.

  • Russell N, Grossmann M (2021). Management of bone and metabolic effects of androgen deprivation therapy. Urol Oncol 39 (10): 704-712. DOI.org/10.1016/j.urolonc.2018.10.007. 

  • Nolan BJ, Brownhill A, Bretherton I, Wong P, Fox S, Locke P, Russell N, Grossmann M, Zajac JD, Cheung A (2020). Relationships between body mass index with oral estradiol dose and serum estradiol concentration in transgender adults undergoing feminising hormone therapy. Ther Adv Endocrinol (11). DOI: 10.1177/2042018820924543.

  • Atallah P, Kanaan R, Russell N, Allebone R, Grossmann M (2020). Cognitive function in prostate cancer patients on androgen deprivation therapy: A case-control study. Gen Hosp Psychiatry 67: 152-153. DOI: 10.1017/j.genhosppsych.2020.04.005.

  • Russell N, Grossmann M (2019). Mechanisms in Endocrinology: Estradiol as a male hormone. Eur J Endocrinol 181 (1): R23-R43. DOI: 10.1530/EJE-18-1000.

  • Russell N, Hoermann R, Cheung A, Ching M, Zajac JD, Handelsman DJ, Grossmann M (2018). Short-term effects of transdermal estradiol in men undergoing androgen deprivation therapy for prostate cancer: a randomized placebo-controlled trial. Eur J Endocrinol 178 (5): 565-576. DOI: 10.1530/EJE-17-1072.

  • Russell N, Cheung A, Grossmann M (2017). Estradiol for the mitigation of adverse effects of androgen deprivation therapy. Endocr Relat Cancer 24 (8):R297-R313. DOI: 10.1530/ERC-17-0153.

  • Russell N, O’Brien RC (2016). Diabetes and Hypertension: Is treatment of hyperglycaemia useful? Dialog Cardiovasc Med 21 (2): 136-146.

  • Russell NDF, Cooper ME (2015). 50 years forward: mechanisms of hyperglycaemia-driven diabetic complications. Diabetologia 58 (8): 1708-1714. DOI: 10.1007/s00125-015-3600-1.

  • Russell N, Delatycki M, Grossmann M (2015). Metastatic phaeochromocytoma in a 23-year-old woman with an unclassified variant in the von Hippel Lindau disease gene: How can the pathogenicity of this variant be determined? Clin Endocrinol 83 (1): 15-19. DOI: 10.1111/cen.12710.

  • Hanssen NM, Russell N, Cooper ME (2015). Recent advances in glucose-lowering treatment to reduce diabetic kidney disease. Expert Opin Pharmaco 16 (9): 1325-1333. DOI: 10.1517/14656566.2015.1041502.

Editorials & letters in refereed journals

  • Wang R, Colman PG, Kyi M, Russell N, Fourlanos S (2021). Longitudinal prevalence of inpatient diabetes mellitus in an Australian hospital across five decades: 1972-2019. Intern Med J 51: 814-815. DOI: 10.1111/imj.15322

  • Russell N (2019). End-of-life care in hospital. Intern Med J 49 (8): 1056. DOI: 10.1111/imj.14385

  • Russell N, Grossmann M (2016). Plasma miRNA expression profile in the diagnosis of late-onset hypogonadism. Asian J Androl 18 (5): 713-715. DOI: 10.4103/1008-682X.182819

  • Russell N, Stevenson AD (2015). Colonoscopy in young women. Intern Med J 45 (11): 1198. DOI: 10.1111/imj.12852.

Book chapters

  • Zajac JD, Seeman E, Russell N, Ramchand SK, Bretherton I, Grossmann M, Davey R (2020). Chapter: Testosterone. Book: Reference Module in Biomedical Sciences. ElsevierDOI.org/10.1016/B978-0-12-801238-3.11263-2

  • Revised and updated ‘Male Androgen Deficiency’ chapter in Therapeutic Guidelines Sexual and Reproductive Health Version 6. Therapeutic Guidelines 2020.

  • Revised and updated ‘Low Libido in Males’ chapter in Therapeutic Guidelines Sexual and Reproductive Health Version 6. Therapeutic Guidelines 2020.

  • Revised and updated ‘Erectile Dysfunction’ chapter in Therapeutic Guidelines Sexual and Reproductive Health Version 6. Therapeutic Guidelines 2020.

Invited conference presentations

  • Russell N (2023). Hormone Dependent Cancers Symposium: Estradiol for men undergoing androgen deprivation therapy for prostate cancer. ESA-SRB Annual Scientific Meeting, 26-29 Nov 2023.

  • Russell N (2021). ESA live webinar: Inpatient hyponatraemia: why it matters and how to manage it in 2021. RACP Congress, 29 Apr - 14 May 2021.

  • Russell N (2021). Symposium presentation: Estradiol in men with metabolic disorders. 19th International Congress of Endocrinology, ICE Virtual 2021, 24-28 Feb 2021.

  • Russell N (2020). Inpatient hyponatraemia: beyond fluid restriction. Proceedings of the sixty-third annual conference of the Endocrine Society of Australia, ESA Virtual, 31 Oct-1 Nov 2020.

  • Russell N (2019). Hyponatraemia - update for general physicians. Proceedings of the annual scientific meeting of the Internal Medicine Society of Australia and New Zealand, Melbourne Australia 5-7 Sept 2019.

Conference abstracts

  • Russell N (2023). Effects of estradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trial. ESA-SRB Annual Scientific Meeting, 26-29 Nov 2023.

  • Russell N, Hoermann R, Ghasem-Zadeh A, Cheung AS, Zajac JD, Handelsman DJ, Grossmann M (2021). Effects of estradiol on bone density and fat mass in men undergoing androgen deprivation therapy for prostate cancer: a randomized placebo-controlled trial. ESA-SRB-ANZBMS 2021, 21-24 November 2021. Abstract 140.

  • Russell N, Allebone J, Dhandash O, Hoermann R, Cheung AS, Zajac JD, Handelsman DJ, Kannan RA, Grossmann M (2021). Effects of estradiol on cognition in men undergoing androgen deprivation therapy for prostate cancer: a randomized placebo-controlled trial. ESA-SRB-ANZBMS 2021, 21-24 November 2021. Abstract 194.

  • Zanker J, Sim M, …, Russell N, …, Daly R, Scott D (2021). The Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Sarcopenia Diagnosis and Management Task Force: Findings from the consumer Delphi Process. Australasian Journal on Ageing 40 (1): 55-56.

  • Zanker J, Sim M, …, Russell N, …, Daly R, Scott D (2021). The Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Sarcopenia Diagnosis and Management Task Force: Findings from the expert Delphi Process. Australasian Journal on Ageing 40 (1): 56-57.

  • Nolan BJ, Brownhill A, …, Russell N, …, Zajac J, Cheung A (2020). Estradiol dose and concentrations in transfeminine individuals. J Endocr Soc 4 (Suppl 1) . Abstract ID: SUN-039. DOI 10.1210/jendso/bvaa046.877.

  • Wang R, Kyi M, …, Russell N, …, Johnson D, Fourlanos S (2019). Diabetes and acute impaired glycaemia affects two thirds of inpatients: point-prevalence study in a tertiary hospital. Proceedings of the annual scientific meeting of the Australasian Diabetes Congress, Sydney Australia 21-33 August 2019. Abstract ID: 243.

  • Russell N, Delatycki M, Grossmann M (2014). Case report: a 23-year-old woman with malignant phaeochromocytoma. Proceedings of the Endocrine Society of Australia Clinical Weekend, Torquay Australia 22-24 August 2014. Abstract ID: 006.

  • Russell N, Varadarajan S (2013). A young man with refractory acromegaly. Proceedings of the fifty-sixth annual conference of the Endocrine Society of Australia, Sydney Australia 25-28 August 2013. Abstract ID: 354.

  • Russell N, Russell D, Nanayakkara N, Seymour C, Colman PG, Fourlanos S (2012). Doubling of diabetes prevalence in hospital inpatients from 1996-2012. Proceedings of the annual scientific meeting of the Australian Diabetes Society and Australian Diabetes Educators Association, Gold Coast Australia 29-31 August 2012. Abstract ID: 304.

Non-refereed articles

  • Russell N, Grossmann M (2016). Not a benign condition (Hyponatraemia therapy update part 2). Australian Doctor 5 August 2016: 31-35.

  • Russell N, Grossmann M (2016). Water balance (Hyponatraemia therapy update part 1). Australian Doctor 29 July 2016: 31-34.

  • Russell N, Cooper ME (2015). Type 2 diabetes management in Australia: where are we and where are we headed? Diabetes Management Journal 2: 4-5.